ALNY vs CBFV · P/E 76, rev $1.29B vs P/E 26, rev $40.6M
Alnylam Pharmaceuticals Inc (ALNY) versus CB Financial Services Inc (CBFV) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
CB Financial Services Inc (CBFV) is a banks - regional company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported CBFV revenue for 2026-06-30 was $40.6M. Net income was $8.2M. CBFV currently screens at market cap $172.1M and trailing P/E 26.1.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. CBFV currently screens at market cap $172.1M and trailing P/E 26.1.
Not investment advice. Open the ALNY and CBFV stock pages for the full models.
Not investment advice.